Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Karena MeehanAlan Breier

Abstract

This double-blind study investigated the efficacy and safety of rapid-acting intramuscular olanzapine in treating agitation associated with Alzheimer's disease and/or vascular dementia. At 2 h, olanzapine (5.0 mg, 2.5 mg) and lorazepam (1.0 mg) showed significant improvement over placebo on the PANSS Excited Component (PANSS-EC) and Agitation-Calmness Evaluation Scale (ACES), and both 5.0 mg olanzapine and lorazepam showed superiority to placebo on the Cohen-Mansfield Agitation Inventory. At 24 h, both olanzapine groups maintained superiority over placebo on the PANSS-EC; lorazepam did not. Olanzapine (5.0 mg) and lorazepam improved ACES scores more than placebo. Simpson-Angus and Mini-Mental State Examination scores did not change significantly from baseline. Sedation (ACES > or =8), adverse events, and laboratory analytes were not significantly different from placebo for any treatment. No significant differences among treatment groups were seen in extrapyramidal symptoms or in corrected QT interval at either 2 h or 24 h, and no significant differences among treatment groups were seen in vital signs, including orthostasis. Intramuscular injection of olanzapine may therefore provide substantial benefit in rapidly treating inpat...Continue Reading

Citations

May 29, 2001·International Journal of Geriatric Psychiatry·N KarS Sengupta
Nov 1, 2006·Current Neurology and Neuroscience Reports·Philip S WangSebastian Schneeweiss
Dec 24, 2003·Journal of Psychiatric Research·Dilip V Jeste, Christian R Dolder
Jun 18, 2003·The American Journal of Emergency Medicine·John BattagliaPadraig Wright
Oct 16, 2010·International Psychogeriatrics·David R Lee, Alan J Thomas
Feb 18, 2006·Nature Reviews. Drug Discovery·Jeffrey L Cummings, Kate Zhong
Feb 14, 2006·Psychiatry and Clinical Neurosciences·Shinji SatoTakashi Asada
Jun 23, 2010·Health Information and Libraries Journal·Mihaela Bucur, Clive Adams
Mar 2, 2006·Drugs & Aging·Carlo CaltagironeUNKNOWN Italian Association of Psychogeriatrics
May 27, 2005·Drugs·John Battaglia
May 31, 2007·Clinical Drug Investigation·Pietro GareriGiovambattista De Sarro
Sep 11, 2009·Indian Journal of Psychiatry·Chittaranjan Andrade, Rajiv Radhakrishnan
Feb 28, 2014·CNS Spectrums·Leslie Citrome, Jan Volavka
Jan 5, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Michael D LesemJames V Cassella
Sep 15, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Nathan Herrmann, Krista L Lanctôt
Feb 5, 2009·The Journal of Clinical Psychiatry·Theodore D SatterthwaiteStanley N Caroff
Dec 24, 2005·Harvard Review of Psychiatry·Dilip V JesteCarl Salzman
Nov 17, 2007·Aging Clinical and Experimental Research·Giovanni B FrisoniOrazio Zanetti
Aug 16, 2003·Journal of Clinical Psychopharmacology·Robert W BakerAngela L Hill
Sep 16, 2006·Journal of Clinical Psychopharmacology·Gabriella GobbiNancy Leblanc
Apr 7, 2007·Journal of Clinical Psychopharmacology·Dan L ZimbroffDan A Oren
Oct 6, 2006·Current Opinion in Anaesthesiology·Christian Verborgh
Jan 25, 2006·Journal of Psychiatric Practice·Glenn W Currier, Rossella Medori
May 25, 2007·Journal of Psychiatric Practice·Glenn W CurrierDavid T Crandall
Apr 20, 2010·Clinical Therapeutics·Scott L Zeller, Robert W Rhoades
Nov 26, 2009·Emergency Medicine Clinics of North America·Victoria A Coburn, Mark B Mycyk
Feb 8, 2008·Schizophrenia Research·Christian G HuberBenno G Schimmelmann
Oct 1, 2007·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Nathan HerrmannPaul G Lysy
Mar 14, 2007·Journal of the American Medical Directors Association·Barbara J ZarowitzEric G Tangalos
Aug 19, 2003·Human Psychopharmacology·F Humble, M Berk
Apr 2, 2008·Emergency Medicine Australasia : EMA·Jonathan C Knott, Geoffrey K Isbister
Jun 17, 2011·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Christopher R CarpenterUNKNOWN Society for Academic Emergency Medicine (SAEM) Geriatric Task Force

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here